Rhode Island 2025 Regular Session

Rhode Island Senate Bill S0115

Introduced
1/31/25  

Caption

Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.

Impact

The impact of S0115 is significant as it amends existing insurance laws to improve coverage for vital diabetes medications. By eliminating out-of-pocket costs associated with glucagon auto-injectors, the bill could potentially lead to better health outcomes for individuals prone to severe hypoglycemic episodes. The requirement applies broadly across all health insurance contracts issued in Rhode Island, thereby establishing a standardized level of care that helps reduce barriers for patients in need of these life-saving treatments.

Summary

Bill S0115 mandates health insurance policies in Rhode Island to cover at least one type of glucagon auto-injector, nasal spray, or a formulation that does not require reconstitution, beginning January 1, 2026. This requirement aims to enhance the availability of glucagon, a crucial medication for treating hypoglycemia, especially in emergency situations where rapid intervention is necessary. By ensuring that two auto-injectors can be obtained without copayment or deductible every twelve months, the bill addresses both accessibility and affordability issues related to essential medications.

Contention

While generally supported for its intent to increase access to necessary medications, S0115 may encounter opposition from some insurance companies concerned about the financial implications of expanded coverage mandates. Critics could argue that such legislation might lead to increased insurance premiums or could incentivize overutilization of glucagon products. Nevertheless, supporters argue that the health benefits of having this medication readily available outweigh these potential drawbacks, marking a significant step forward in patient care and safety.

Companion Bills

No companion bills found.

Previously Filed As

RI H5628

Mandates all health insurance contracts, plans, or policies provide the same reimbursement to independent healthcare facilities as that of hospital affiliated facilities where the same healthcare service is provided.

RI H5082

Limits copays, coinsurance or office deductibles for services of a physical therapist to the amount authorized for the services of a primary care physician or osteopath on or after January 1, 2026.

RI S0051

Limits copays, coinsurance or office deductibles for services of a physical therapist to the amount authorized for the services of a primary care physician or osteopath on or after January 1, 2026.

RI H6158

Mandates insurance coverage for scalp cooling treatments for breast cancer patients undergoing chemotherapy to prevent hair loss during chemotherapy treatments.

RI S0263

Requires coverage for acute mental health crisis mobile response and stabilization services to eligible individuals enrolled as plan beneficiaries.

RI H6118

Requires coverage for acute mental health crisis mobile response and stabilization services to eligible individuals enrolled as plan beneficiaries.

RI H5173

Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.

RI H5256

Provides for equal pay for healthcare providers.

Similar Bills

RI H5173

Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.

UT SB0146

Glucagon Amendments

MA H671

Relative to undesignated glucagon rescue therapies in schools

NJ A1882

Concerns administration of ready-to-use undesignated glucagon rescue therapy in public schools.

FL H0597

Diabetes Management in Schools

TX SB204

Relating to insurance coverage for certain devices used in the treatment of diabetes.

WV SB92

Glucagon for Schools Act

KY HB75

AN ACT relating to undesignated glucagon.